First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts
NCT02106260
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Cutaneous Warts
Interventions
DRUG:
CLS003
Sponsor
Maruho Co., Ltd.